Journal
CLINICAL INFECTIOUS DISEASES
Volume 63, Issue 7, Pages 954-958Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciw398
Keywords
NDM; CRE; ceftazidime-avibactam; bacteremia; carbapenemase
Categories
Ask authors/readers for more resources
Resistance to the novel beta-lactam/beta-lactamase inhibitor combination ceftazidime-avibactam (CAZ-AVI) among carbapenem-resistant Enterobacteriaceae (CRE) has infrequently been reported in the United States. We report unexpectedly high rates of resistance to CAZ-AVI in CRE bloodstream isolates at our institution associated with the nonoutbreak spread of New Delhi metallo-beta-lactamase in diverse Enterobacteriaceae species.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available